Lakeshore Biopharma Co., Ltd. (LSBCF) — SEC Filings
Lakeshore Biopharma Co., Ltd. (LSBCF) — 2 SEC filings. Latest: 6-K (Apr 29, 2026). Includes 2 6-K.
View Lakeshore Biopharma Co., Ltd. on SEC EDGAR
Overview
Lakeshore Biopharma Co., Ltd. (LSBCF) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Apr 29, 2026: LakeShore Biopharma Co., Ltd. announced on April 29, 2026, that it has entered into an amended merger agreement. This filing includes a press release and an amendment to the original agreement and plan of merger, indicating a revised deal structure or terms for a previously announced transaction.
Sentiment Summary
Across 2 filings, the sentiment breakdown is: 1 neutral, 1 mixed. The dominant filing sentiment for Lakeshore Biopharma Co., Ltd. is neutral.
Filing Type Overview
Lakeshore Biopharma Co., Ltd. (LSBCF) has filed 2 6-K with the SEC between Mar 2026 to Apr 2026.
Recent SEC Filings (2)
| Date | Form | Description | Risk |
|---|---|---|---|
| Apr 29, 2026 | 6-K | LakeShore Biopharma Amends Merger Agreement | medium |
| Mar 25, 2026 | 6-K | LakeShore Biopharma Receives Revised Preliminary Non-Binding Proposal |
Risk Profile
Risk Assessment: Of LSBCF's 1 recent filings, 0 were flagged as high-risk, 1 as medium-risk, and 0 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Top Tags
merger-agreement (1) · amendment (1) · foreign-issuer (1) · corporate-action (1) · merger-acquisition (1) · proposal (1) · press-release (1)
Frequently Asked Questions
What are the latest SEC filings for Lakeshore Biopharma Co., Ltd. (LSBCF)?
Lakeshore Biopharma Co., Ltd. has 2 recent SEC filings from Mar 2026 to Apr 2026, including 2 6-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of LSBCF filings?
Across 2 filings, the sentiment breakdown is: 1 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Lakeshore Biopharma Co., Ltd. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Lakeshore Biopharma Co., Ltd. (LSBCF) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Lakeshore Biopharma Co., Ltd.?
Financial highlights for Lakeshore Biopharma Co., Ltd. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for LSBCF?
Investment thesis data for LSBCF will be available once enriched filings are processed.
Who are the key executives at Lakeshore Biopharma Co., Ltd.?
Executive information for Lakeshore Biopharma Co., Ltd. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Lakeshore Biopharma Co., Ltd. stock?
Of LSBCF's 1 assessed filings, 0 were flagged high-risk, 1 medium-risk, and 0 low-risk.
What are recent predictions and forward guidance from Lakeshore Biopharma Co., Ltd.?
Forward guidance and predictions for Lakeshore Biopharma Co., Ltd. are extracted from SEC filings as they are enriched.